The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2.7-fold increased risk of polycystic ovary syndrome in a Sardinian population

Clinical Endocrinology

Volumn 77, Issue 1, 2012, Pages 113-119

  Capalbo, A ^a   Sagnella, F ^a   Apa, R ^a   Fulghesu, A M ^b   Lanzone, A ^c   Morciano, A ^a   Farcomeni, A ^d   Gangale, M F ^a   Moro, F ^a   Martinez, D ^a   Ciardulli, A ^a   Palla, C ^a   Uras, M L ^a   Spettu, F ^e   Cappai, A ^b   Carcassi, C ^b   Neri, G ^a   Tiziano, Francisco D ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c OASI RESEARCH INSTITUTE IRCCS   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e Ospedale Nostra Signora Delle Mercede   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN RECEPTOR; LUTEINIZING HORMONE;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CASE CONTROL STUDY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; OUTPATIENT DEPARTMENT; OVARY POLYCYSTIC DISEASE; PHENOTYPE; PRIORITY JOURNAL; RISK;

ADOLESCENT; ADULT; ALLELES; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETICS, POPULATION; HUMANS; ITALY; POLYCYSTIC OVARY SYNDROME; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, LH; RISK FACTORS; YOUNG ADULT;

EID: 84862012197     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2012.04372.x     Document Type: Article

References (42)

1. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertility and Sterility, 81, 19-25.
2. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Human Reproduction, 19, 41-47.
3. Lunde, O., Magnus, P., Sandvik, L. et al. (1989) Familial clustering in the polycystic ovarian syndrome. Gynecologic and Obstetric Investigation, 28, 23-30. (Pubitemid 19181195)
4. Azziz, R. & Kahsar-Miller, M.D. (2000) Family history as a risk factor for the polycystic ovary syndrome. Journal of Pediatric Endocrinology and Metabolism, 13(Suppl 5), 1303-1306.
5. Kahsar-Miller, M.D., Nixon, C., Boots, L.R. et al. (2001) Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and Sterility, 75, 53-58. (Pubitemid 32042114)
6. Carey, A.H., Chan, K.L., Short, F. et al. (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clinical Endocrinology, 38, 653-658. (Pubitemid 23168483)
7. Govind, A., Obhrai, M.S. & Clayton, R.N. (1999) Polycystic ovaries are inherited as an autosomal dominant trait: analysis of 29 polycystic ovary syndrome and 10 control families. Journal of Clinical Endocrinology and Metabolism, 84, 38-43. (Pubitemid 29036677)
8. Jahanfar, S., Eden, J.A., Warren, P. et al. (1995) A twin study of polycystic ovary syndrome. Fertility and Sterility, 63, 478-486.
9. Jahanfar, S., Eden, J.A., Nguyen, T. et al. (1997) A twin study of polycystic ovary syndrome and lipids. Gynecological Endocrinology, 11, 111-117. (Pubitemid 27196738)
10. Kahsar-Miller, M. & Azziz, R. (1999) Heritability and the risk of developing androgen excess. Journal of Steroid Biochemistry and Molecular Biology, 69, 261-268.
11. Sam, S., Coviello, A.D., Sung, Y.A. et al. (2008) Metabolic phenotype in the brothers of women with polycystic ovary syndrome. Diabetes Care, 31, 1237-1241.
12. Sam, S., Sung, Y.A., Legro, R.S. et al. (2008) Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome. Metabolism, 57, 84-89. (Pubitemid 350234977)
13. Diamanti-Kandarakis, E. & Piperi, C. (2005) Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Human Reproduction Update, 11, 631-643. (Pubitemid 41631312)
14. Franks, S., Gharani, N. & McCarthy, M. (2001) Candidate genes in polycystic ovary syndrome. Human Reproduction Update, 7, 405-410. (Pubitemid 32655326)
15. Holte, J. (1998) Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style? Journal of Endocrinological Investigation, 21, 589-601.
16. Crosignani, P.G. & Nicolosi, A.E. (2001) Polycystic ovarian disease: heritability and heterogeneity. Human Reproduction Update, 7, 3-7. (Pubitemid 32111960)
17. Strauss III, J.F. (2003) Some new thoughts on the pathophysiology and genetics of polycystic ovary syndrome. Annals of the New York Academy of Sciences, 997, 42-48.
18. Chen, Z.J., Zhao, H., He, L. et al. (2011) Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2p16.3, 2p21 and 9q33.3. Nature Genetics, 43, 55-59.
19. Dos Santos, E., Dieudonné, M.N., Leneveu, M.C. et al. (2007) In vitro effects of chorionic gonadotropin hormone on human adipose development. Journal of Endocrinology, 194, 313-325. (Pubitemid 47249670)
20. Atger, M., Mishrahi, M., Sar, S. et al. (1995) Structure of the human luteinizing hormone-choriogonadotropin receptor gene: unusual promoter and 59 non-coding regions. Molecular and Cellular Endocrinology, 111, 113-123.
21. Nelson-Degrave, V.L., Wickenheisser, J.K., Hendricks, K.L. et al. (2005) Alterations in mitogen-activated protein kinase kinase and extracellular regulated kinase signaling in theca cells contribute to excessive androgen production in polycystic ovary syndrome. Molecular Endocrinology, 19, 379-390. (Pubitemid 40223462)
22. Piersma, D., Verhoef-Post, M., Berns, E.M. et al. (2007) LH receptor gene mutations and polymorphisms: An overview. Molecular and Cellular Endocrinology, 2, 282-286. (Pubitemid 44792342)
23. Zhang, F.P., Huhtaniemi, I., Kero, J. et al. (2002) Transgenic and knockout mouse models for the study of luteinizing hormone and luteinizing hormone receptor function. Molecular and Cellular Endocrinology, 187, 49-56. (Pubitemid 34436932)
24. Nakabayashi, K., Kudo, M., Hsueh, A.J. et al. (2003) Activation of the luteinizing hormone receptor in the extracellular domain. Molecular and Cellular Endocrinology, 202, 139-144. (Pubitemid 36593405)
25. Gromoll, J., Gudermann, T. & Greshniok, A. (1999) Male pseudohermaphroditism due to an inactivating mutation in the extracellular domain of the luteinizing hormone receptor. Experimental and Clinical Endocrinology and Diabetes, 107(Suppl 1), v005.
26. Huhtaniemi, I.T. & Themmen, A.P. (2005) Mutations in human gonadotropin and gonadotropin-receptor genes. Endocrine, 26, 207-218.
27. Kremer, H., Mariman, E., Otten, B.J. et al. (1993) Cosegregation of missense mutations of the luteinizing hormone receptor gene with familial male-limited precocious puberty. Human Molecular Genetics, 2, 1779-1783. (Pubitemid 23326599)
28. Kremer, H., Kraaij, R., Toledo, S.P. et al. (1995) Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene. Nature Genetics, 9, 160-164.
29. Latronico, A.C., Anasti, J., Arnhold, I.J. et al. (1996) Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene. New England Journal of Medicine, 334, 507-512. (Pubitemid 26067739)
30. Reiter, E.O., Brown, R.S., Longcope, C. et al. (1984) Male-limited familial precocious puberty in three generations. Apparent Leydig-cell autonomy and elevated glycoprotein hormone alpha subunit. New England Journal of Medicine, 311, 515-519. (Pubitemid 14059354)
31. Richter-Unruh, A., Martens, J.W., Verhoef-Post, M. et al. (2002) Leydig cell hypoplasia: cases with new mutations, new polymorphisms and cases without mutations in the luteinizing hormone receptor gene. Clinical Endocrinology, 56, 103-112. (Pubitemid 34107327)
32. Richter-Unruh, A., Wessels, H.T., Menken, U. et al. (2002) Male LH-independent sexual precocity in a 3.5-year-old boy caused by a somatic activating mutation of the LH receptor in a Leydig cell tumor. Journal of Clinical Endocrinology and Metabolism, 87, 1052-1056. (Pubitemid 36121064)
33. Richter-Unruh, A., Verhoef-Post, M., Malak, S. et al. (2004) Leydig cell hypoplasia: absent luteinizing hormone receptor cell surface expression caused by a novel homozygous mutation in the extracellular domain. Journal of Clinical Endocrinology and Metabolism, 89, 5161-5167. (Pubitemid 39391464)
34. Rodien, P., Cetani, F., Costagliola, S. et al. (1998) Evidences for an allelic variant of the human LC/CG receptor rather than a gene duplication: functional comparison of wild-type and variant receptors. Journal of Clinical Endocrinology and Metabolism, 83, 4431-4434. (Pubitemid 29100148)
35. Rosenthal, S.M., Grumbach, M.M. & Kaplan, S.L. (1983) Gonadotropin-independent familial sexual precocity with premature Leydig and germinal cell maturation (familial testotoxicosis): effects of a potent luteinizing hormone-releasing factor agonist and medroxyprogesterone acetate therapy in four cases. Journal of Clinical Endocrinology and Metabolism, 57, 571-579. (Pubitemid 13005524)
36. Piersma, D., Berns, E.M., Verhoef-Post, M. et al. (2006) A Common Polymorphism Renders the Luteinizing Hormone Receptor Protein More Active by Improving Signal Peptide Function and Predicts Adverse Outcome in Breast Cancer Patients. The Journal of Clinical Endocrinology & Metabolism, 91, 1470-1476.
37. Bhowmick, N., Huang, J., Puett, D. et al. (1996) Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone/chorionic gonadotropin receptor by site-directed mutagenesis and modeling. Molecular Endocrinology, 10, 1147-1159. (Pubitemid 26299223)
38. Arcos-Burgos, M. & Muenke, M. (2002) Genetics of population isolates. Clinical Genetics, 61, 233-247. (Pubitemid 36372640)
39. Fulghesu, A.M., Ciampelli, M., Belosi, C. et al. (2001) A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertility and Sterility, 76, 326-3.
40. Guastella, E., Longo, R.A. & Carmina, E. (2010) Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertility and Sterility, 94, 2197-2201.
41. Yilmaz, M., Isaoglu, U., Delibas, I.B. et al. (2011) Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria. Journal of Obstetrics and Gynaecology Research, 37, 1020-1026.
42. Valkenburg, O., Uitterlinden, A.G., Piersma, D. et al. (2009) Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Human Reproduction, 24, 2014-2022.